The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19
Clinical trial NCT04285190 · WITHDRAWN
Trial details
- NCT number
- NCT04285190
- Sponsor
- Tasly Pharmaceuticals, Inc.
- Status
- WITHDRAWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-26
- Primary completion
- 2020-04-15
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.